According to the American Diabetes Association, approximately 8.4 million people in the United States need insulin to survive.

Massachusetts is the latest state going after insulin makers and the intermediaries officials accuse of price gouging. Why it matters: Diabetes patients are often paying hundreds of dollars a month or more for life-saving medicine when the costs of production remain largely unchanged,